Document is current
Any future updates will be listed below
-
Authors
Coletti, Kristen
Hershey, Jennifer A.
Devine, Matthew
Taft, Jennifer
Schinella, Jeff
Ajiboye, Sekinah
Gibbs, Kathleen
Lambert, Michele P.
Friedman, David
Thom, Christopher S. https://orcid.org/0000-0003-1830-9922
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL156052)
Hartwell Foundation Individual Biomedical Research Award
- License Information
-
More Information
Article History
Received: 18 February 2025
Revised: 31 May 2025
Accepted: 25 June 2025
First Online: 9 July 2025
Competing interests
: MPL has no conflicts of interest relevant to this article to disclose. MPL is an advisory board member for Octapharma, Dova, Principia, Janssen, Sobi, argenx, PDSA, 22qSociety and CdLS Foundation; a consultant for Novartis Dova, Principia, argenx, Rigel, Sobi, Sanofi, and Janssen, and has received research funding from FWGBD, PDSA, NIH, Sysmex, NovarAtis, Principia, Janssen, argenx, Dova, Octapharma, and Sanofi. None of these is related to this project. The other authors have no conflicts of interest to disclose.
